Relief Therapeutics Holding SA
RLFTFDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Prednisolone | Phase 2 | HIV Disease Progression | - | - |
Frequently asked questions
What is in Relief Therapeutics Holding SA's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Relief Therapeutics Holding SA's (RLFTF) pipeline across Phase 2. Its lead program is Prednisolone (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Relief Therapeutics Holding SA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Relief Therapeutics Holding SA (RLFTF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track RLFTF biotech catalysts?→
Add RLFTF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Relief Therapeutics Holding SA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.